These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18281444)

  • 1. Albendazole therapy in patients with solitary cerebral cysticercus granuloma. Is it effective?
    Rajshekhar V
    J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):238-9. PubMed ID: 18281444
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebral cysticercus granuloma associated with a subdural effusion.
    Rajshekhar V
    Neurol India; 2001 Jun; 49(2):182-4. PubMed ID: 11447442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albendazole therapy for solitary persistent cysticercus granuloma.
    Thussu A; Arora A; Lal V; Prabhakar S; Sawhney IM
    Neurol India; 2001 Mar; 49(1):95-7. PubMed ID: 11303254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-day versus 15-day course of albendazole therapy in solitary cysticercus granuloma: an open label randomized trial.
    Khurana N; Garg RK; Verma R; Malhotra HS; Singh MK; Shukla R
    J Neurol Sci; 2012 May; 316(1-2):36-41. PubMed ID: 22342396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albendazole and Corticosteroids for the Treatment of Solitary Cysticercus Granuloma: A Network Meta-analysis.
    Zhao BC; Jiang HY; Ma WY; Jin DD; Li HM; Lu H; Nakajima H; Huang TY; Sun KY; Chen SL; Chen KB
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004418. PubMed ID: 26849048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis.
    Otte WM; Singla M; Sander JW; Singh G
    Neurology; 2013 Jan; 80(2):152-62. PubMed ID: 23269591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures.
    Rajshekhar V
    Neurology; 1993 Jun; 43(6):1238-40. PubMed ID: 8170573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure motor monoparesis: solitary cysticercus granuloma.
    Giri P; Shukla R; Patil TB; Mehta V
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24343804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Millairy neurocysticercosis.
    Sundaresan S; Sanklecha M
    J Pediatr; 2014 Dec; 165(6):1270-1270.e2. PubMed ID: 25179531
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy.
    Singhi P; Ray M; Singhi S; Khandelwal N
    J Child Neurol; 2000 Apr; 15(4):207-13. PubMed ID: 10805184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure and radiological outcomes in children with solitary cysticercous granulomas with and without albendazole therapy: a retrospective case record analysis.
    Gulati S; Jain P; Sachan D; Chakrabarty B; Kumar A; Pandey RM; Gupta AK
    Epilepsy Res; 2014 Sep; 108(7):1212-20. PubMed ID: 24908563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three day albendazole therapy in patients with a solitary cysticercus granuloma: a randomized double blind placebo controlled study.
    Chaurasia RN; Garg RK; Agarwall A; Kohli N; Verma R; Singh MK; Shukla R
    Southeast Asian J Trop Med Public Health; 2010 May; 41(3):517-25. PubMed ID: 20578537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
    Thussu A; Chattopadhyay A; Sawhney IM; Khandelwal N
    J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):272-5. PubMed ID: 17928325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocysticercosis--is the elimination of parasites beneficial?
    Sotelo J
    N Engl J Med; 2004 Jan; 350(3):280-2. PubMed ID: 14724309
    [No Abstract]   [Full Text] [Related]  

  • 15. Albendazole in neurocysticercosis.
    Padma MV; Behari M; Misra NK; Ahuja GK
    Natl Med J India; 1995; 8(6):255-8. PubMed ID: 8520442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.
    Takayanagui OM; Bonato PS; Dreossi SA; Lanchote VL
    Br J Clin Pharmacol; 2002 Aug; 54(2):125-30. PubMed ID: 12207631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albendazole therapy for neurocysticercosis.
    Takayanagui OM
    Neurology; 1998 Mar; 50(3):834-5. PubMed ID: 9521303
    [No Abstract]   [Full Text] [Related]  

  • 18. Albendazole therapy for neurocysticercosis.
    Ko DY; Chang GY
    Neurology; 1998 Mar; 50(3):834-5. PubMed ID: 9521302
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurocysticercosis in pregnancy: a case initially diagnosed as eclampsia.
    Suarez VR; Iannucci TA
    Obstet Gynecol; 1999 May; 93(5 Pt 2):816-8. PubMed ID: 10912405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of albendazole therapy in two common types of parenchymal neurocysticercosis.
    Garg RK; Kar AM; Jain S
    J Assoc Physicians India; 1995 Oct; 43(10):706-7. PubMed ID: 8773009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.